Our study is in accordance to a report of Bourikas et al where they have shown that ciprofloxacin exerts its antiproliferative effects on colon cancer cells by arresting them in S-phase in a TGF-β1 dependent manner. The gene discussed is TGFB1; the disease is colonic neoplasm.